Molecular characteristics of Acinetobacter baumannii and the changes of efflux pump expression under tigecycline pressure
10.16571/j.cnki.1008-8199.2020.01.004
- VernacularTitle: 鲍曼不动杆菌分子特征及其在替加环素压力下外排泵表达的变化
- Author:
Jian-jun CHENG
1
;
Dinesh KESAVAN
1
;
Qing YIN
2
;
Hui-xuan WANG
1
;
Wei CAI
1
;
Jian-guo CHEN
3
;
Zhao-liang SU
1
;
Hua-xi XU
1
Author Information
1. Institute of Laboratory Medicine, Jiangsu University, Zhenjiang 212013, Jiangsu, China
2. Laboratory Department of Affiliated Hospital, Jiangsu University, Zhenjiang 212001, Jiangsu, China
3. Laboratory Department of Affiliated People's Hospital, Jiangsu University, Zhenjiang 212002, Jiangsu, China
- Publication Type:Journal Article
- Keywords:
Acinetobacter baumannii;
efflux pumps;
ERIC-PCR;
pulse field gel electrophoresis;
tigecycline;
induction of drug resistance
- From:
Journal of Medical Postgraduates
2020;33(1):18-24
- CountryChina
- Language:Chinese
-
Abstract:
Objective Acinetobacter baumannii (A. baumannii) is a commonly infective bacterium in the hospital. This study aims to analyze its molecular epidemiological characteristics, detect the carrying rate of efflux pump and regulatory protein genes, and investigate the effects of tigecycline on the efflux pump and expression of regulatory protein genes. Methods A total of 183 A. baumannii strains were collected from inpatients of the affiliated hospital of Jiangsu University from May 2017 to March 2019. They were divided into an antimicrobial-resistant group (one or more antimicrobial-resistant strains, 139 strains) and a sensitive group (the drugs in the drug sensitivity test were all non-resistant strains, 44 strains). Repeated sequence PCR was used for homology analysis of the strains, and pulse-field gel electrophoresis (PFGE) was used as the gold standard for homology analysis to verify and compare some strains. PCR was used to detect the occurrence of drug resistance-related genes. Based on homology analysis, efflux pump carrying rate detection and antibiotics sensitivity test results, 6 clinical strains carrying all efflux pump genes but different resistance phenotypes were selected as experimental strains, including sensitive strains (SAB), the multidrug resistance strain (MDRAB) and the extensively drug-resistant strain (XDRAB). All strains were induced in vitro with the minimum inhibitory concentration (MIC) of tigecycline. The induced strains were categorized as induction group, and the same strains cultured in LB agar without tigecycline was used as a control group. MIC was used to analyze the tigecycline susceptibility, and RT-qPCR was used to detect the gene expression of efflux pumps, such as TetB, AbaQ and regulatory proteins (AdeS and BaeS), in drug-resistant strains. Results Homology analysis showed that there were 45 clonal groups in the detected clinical isolates, with no obvious outbreak of epidemic clonal groups. Efflux pumps and regulatory proteins were widely distributed in the clinical isolates, and the expression of AdeB, TetB, AbeS, AdeS in MDRAB and XDRAB is significantly higher than that insensitive group SAB. Continuous in vitro induction with tigecycline could increase the antimicrobial resistance of some clinical strains and even significantly increase the expression levels of efflux pumps and regulatory proteins. Conclusion A. baumannii is widely distributed in the clinic, and efflux pumps and regulatory proteins might play an important role in drug resistance process. The unreasonable use of tigecycline could enhance the tolerance of A. baumannii by up-regulating the expression of some bacterial efflux pumps.
